ArticleDiscover nano2025
Controlled growth of citrate-stabilized gold nanoparticles using a semi-continuous seed-mediated route.
Article in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Gold nanoparticles (AuNPs) as emerging anti-inflammatory agents: mechanisms, therapeutic advances, and future directions-a systematic review and meta-analysis.Inflammopharmacology · 2026Pooled it
- Graphene Oxide (GO) and Gold Nanoparticles (AuNP) Facilitated Electrochemical Biosensing for Lung Cancer Diagnosis.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gold nanoparticles (Au NPs) hold unique optical and electronic properties due to their surface plasmon resonance. The size, shape, and surface chemistry of Au NPs are key parameters for altering their optical properties to fine-tune Au NPs for specific applications. We report a size-controlled synthesis of citrate-stabilized Au NPs via the Turkevich method, followed by their growth through a semi-continuous seed-mediated approach. Au NPs of up to 53 nm were synthesized by controlled addition of chloroauric acid (HAuCl₄) to pre-prepared citrate stabilized Au NP seeds. Our approach leverages the residual sodium citrate from the Turkevich reaction to reduce HAuCl₄ during seed-mediated growth of Au NPs. Notably, we observed that a boiling temperature, as opposed to 70 °C, provided better control over nanoparticle size and morphology. Our method addresses several challenges associated with seed-mediated growth by yielding relatively spherical, monodisperse, citrate-stabilized, water-dispersible Au NPs in a single growth step, without sacrificing yield. Furthermore, a kinetics study revealed a continuous increase in particle diameter over the reaction period, hinting at the continuous and uniform growth of Au NPs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.